Comparison of Outcomes after Transplantation of G-CSF–Stimulated Bone Marrow Grafts versus Bone Marrow or Peripheral Blood Grafts from HLA-Matched Sibling Donors for Patients with Severe Aplastic Anemia
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jul 01, 2011
- Source ID
- 10.1016/j.bbmt.2010.10.029
Entities
People
- Adrian Gee
- Alvaro Urbano Ispizua
- Asad Bashey
- Biju George
- Bruce Camitta
- Christopher Bredeson
- Edmund K Waller
- Fangyu Kan
- Frederick D. Goldman
- Gregory A. Hale
- Haydar Frangoul
- Hillard M Lazarus
- James Russell III
- Judith Marsh
- Kuang-yueh Chiang
- Luis Isola
- Mary Eapen
- Mitchell Sabloff
- Robert Peter Gale
- Roland Chu
- Ruta Brazauskas
- Thomas G. Gross
- Vikas Gupta
Organizations
- AABB
- Aetna
- American Society for Transplantation and Cellular Therapy
- Amgen
- Baxter International
- Blue Cross Blue Shield Association
- Celgene
- CellGenix (Germany)
- Centers for Disease Control and Prevention
- Children’s Leukemia Research Association
- Cubist Pharmaceuticals
- Elevance Health, Inc.
- GE HealthCare
- Health Resources and Services Administration
- Infectious Diseases Society of America
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- National Cancer Institute
- National Marrow Donor Program
- New York Blood Center
- Office of Naval Research
- Oncology Nursing Society
- Otsuka (United States)
- Roche (United States)
- Terumo BCT (United States)
- Vion Pharmaceuticals, Inc.